Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells

<p>Supplementary Figure 2</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Francisco Exposito (16721403) (author)
Diğer Yazarlar:	Miriam Redrado (16721406) (author), Maeva Houry (16721409) (author), Katherine Hastings (16721412) (author), Magdalena Molero-Abraham (16721415) (author), Teresa Lozano (16721418) (author), Jose Luis Solorzano (16721421) (author), Julian Sanz-Ortega (16721424) (author), Vera Adradas (16721427) (author), Ramon Amat (16721430) (author), Esther Redin (16721433) (author), Sergio Leon (16721436) (author), Naroa Legarra (16721439) (author), Javier Garcia (16721442) (author), Diego Serrano (16721445) (author), Karmele Valencia (14962695) (author), Camila Robles-Oteiza (16721448) (author), Giorgia Foggetti (15118568) (author), Nerea Otegui (16721451) (author), Enriqueta Felip (16721454) (author), Juan J. Lasarte (16721457) (author), Luis Paz-Ares (16721460) (author), Jon Zugazagoitia (16721463) (author), Katerina Politi (15313362) (author), Luis Montuenga (16721466) (author), Alfonso Calvo (16721469) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Cancer Biology Immuno-oncology Immunotherapy Combination immunotherapy Lung Cancer Oncogenes & Tumor Suppressors PD-1
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Yazar:: Francisco Exposito (16721403)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Yazar:: Francisco Exposito (16721403)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Yazar:: Francisco Exposito (16721403)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Yazar:: Francisco Exposito (16721403)
Baskı/Yayın Bilgisi: (2025)

Processed single-cell RNA-seq dataset of cancer-associated fibroblasts in breast cancer patients receiving anti–PD-1 therapy
Yazar:: Thang Pham (19938126)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
Yazar:: Caroline Robert (15032672)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
Yazar:: Caroline Robert (15032672)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 3 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
Yazar:: Caroline Robert (15032672)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 4 from Phase I Study of Androgen Deprivation Therapy in Combination with Anti–PD-1 in Melanoma Patients Pretreated with Anti–PD-1
Yazar:: Caroline Robert (15032672)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
Yazar:: Hailong Pang (12841991)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from Intratumoral CD16<sup>+</sup> Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
Yazar:: Hansol Lee (15054787)
Baskı/Yayın Bilgisi: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
Yazar:: Stéphane Fattori (15048281)
Baskı/Yayın Bilgisi: (2025)

Table S2, S4, S5, S6 and S7 from Single-Cell Analysis Reveals a CD4<sup>+</sup> T-cell Cluster That Correlates with PD-1 Blockade Efficacy
Yazar:: Hiroshi Kagamu (14961732)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
Yazar:: Ulka N. Vaishampayan (15051039)
Baskı/Yayın Bilgisi: (2025)

Supplementary File 1 from Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes
Yazar:: Huaibin Ge (15047462)
Baskı/Yayın Bilgisi: (2025)

Datasets for bibliometric analysis of regulatory T cells in gastric cancer (2005-2025)
Yazar:: Houshu Tu (22026668)
Baskı/Yayın Bilgisi: (2025)

TS1-9 from Dynamics of Sequence and Structural Cell-Free DNA Landscapes in Small-Cell Lung Cancer
Yazar:: Lavanya Sivapalan (15314248)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S10 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S11 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S12 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S13 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S14 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S15 from Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non–Small Cell Lung Cancer
Yazar:: Rohit Thummalapalli (17314483)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_9gjgah4m8ejv3japc4aeopaauc